Oliver Wyman October 20, 2023
BlueCross BlueShield North Carolina’s Arif Khan says greater transparency and aligned incentives among stakeholders is critical to getting drug costs under control.
When it comes to the high cost of drugs, there’s plenty of blame to go around.
“You hear a lot of finger pointing and blaming as to who is to (responsible) for high drug costs. I’ll actually make the argument that it’s everybody,” Arif Khan, Vice President, Enterprise Strategy, BlueCross BlueShield of North Carolina, said during an interview at the 2023 Oliver Wyman Health Innovation Summit. “What we...
Today's Sponsors
Today's Sponsor
Topics: Biotechnology, CMS, Conferences / Podcast, Govt Agencies, Insurance, Medicare, Payer, Pharma, Pharma / Biotech, Trends